
Wednesday, July 21, 2021 12:40:52 PM
The LOCAL trial will be conducted across approximately 20 centers in the United States and is expected to enroll up to 792 patients diagnosed as infertile. The primary endpoints of the study are to determine the effectiveness (clinical pregnancy rate) and safety over a period of 7 weeks.

Liked By
Spread the love. Be the first to like this post!
Recent FEMY News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/21/2022 09:03:01 PM
- Maxim Group Keeps Their Buy Rating on Femasys (FEMY) • TipRanks • 12/01/2022 08:15:10 PM
- Analysts’ Top Technology Picks: AppLovin (APP), Femasys (FEMY) • TipRanks • 11/13/2022 02:30:28 PM
- Maxim Group Sticks to Their Buy Rating for Femasys (FEMY) • TipRanks • 11/11/2022 05:55:20 PM
- H.C. Wainwright Reaffirms Their Buy Rating on Femasys (FEMY) • TipRanks • 11/11/2022 03:45:14 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:41:56 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:36:30 PM
- Femasys (FEMY) Gets a Buy from Maxim Group • TipRanks • 10/26/2022 09:56:38 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/20/2022 12:35:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/17/2022 08:49:40 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 10/17/2022 08:20:36 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/12/2022 12:47:28 PM
- Maxim Group Keeps Their Buy Rating on Femasys (FEMY) • TipRanks • 10/11/2022 08:46:13 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/06/2022 12:50:51 PM
- H.C. Wainwright Reaffirms Their Buy Rating on Femasys (FEMY) • TipRanks • 09/29/2022 04:25:06 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/29/2022 12:41:53 PM
- Maxim Group Keeps Their Buy Rating on Femasys (FEMY) • TipRanks • 08/12/2022 11:45:15 AM
- Analysts’ Top Technology Picks: Alpha and Omega (AOSL), Femasys (FEMY) • TipRanks • 08/11/2022 10:30:32 AM
- Chardan Capital Remains a Buy on Femasys (FEMY) • TipRanks • 08/10/2022 11:55:15 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/10/2022 08:12:57 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/10/2022 08:07:25 PM
- Analysts Offer Insights on Technology Companies: PROS Holdings (PRO) and Femasys (FEMY) • TipRanks • 07/29/2022 11:55:29 AM
- H.C. Wainwright Thinks Femasys’ Stock is Going to Recover • TipRanks • 07/29/2022 10:18:15 AM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 07/12/2022 08:01:52 PM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 07/01/2022 08:56:25 PM
FEATURED Hempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201 • Feb 6, 2023 9:30 AM
ILUS Summarizes Its Progress and Projections Following Its 2nd Annual Shareholder Meeting • ILUS • Feb 6, 2023 10:28 AM
Xalles Announces 2022 Results and Organizational Changes • XALL • Feb 6, 2023 8:39 AM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM